Each restricted stock unit represents a contingent right to receive one share of common stock of AMAG Pharmaceuticals, Inc. (the "Issuer").
These shares of common stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's Third Amended and Restated 2007 Equity Incentive Plan (the "Plan") that vests in full on May 1, 2014; however, delivery of the shares is deferred until the earlier of (a) thr
ee years from the date of grant and (b) the date of the director's separation from service to the Issuer.
Grant of stock option pursuant to the Plan. This option vests and becomes exercisable in twenty-four equal monthly installments over two years from the date of grant.
Grant of stock option pursuant to the Plan. This option vests and becomes exercisable in full on May 1, 2014.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here. AMAG Pharmaceuticals next reports earnings on April 21, 2014.
To receive a free e-mail notification whenever AMAG Pharmaceuticals makes a similar move, sign up!
Other recent filings from the company include the following:
Current report, items 1.01, 8.01, and 9.01 - Feb. 26, 2015
Prospectus [Rule 424(b)(5)] - Feb. 26, 2015
Automatic shelf registration statement of securities of well-known seasoned issuers - Feb. 24, 2015
Prospectus [Rule 424(b)(5)] - Feb. 24, 2015
Current report, items 2.01 and 9.01 - Feb. 24, 2015